Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Other Non-Current Assets: 2009-2022

Historic Other Non-Current Assets for Avadel Pharmaceuticals (AVDL) over the last 13 years, with Sep 2022 value amounting to $11.7 million.

  • Avadel Pharmaceuticals' Other Non-Current Assets fell 69.24% to $11.7 million in Q3 2022 from the same period last year, while for Sep 2022 it was $11.7 million, marking a year-over-year decrease of 69.24%. This contributed to the annual value of $33.8 million for FY2021, which is 35.44% up from last year.
  • As of Q3 2022, Avadel Pharmaceuticals' Other Non-Current Assets stood at $11.7 million, which was down 0.42% from $11.8 million recorded in Q2 2022.
  • Avadel Pharmaceuticals' 5-year Other Non-Current Assets high stood at $47.5 million for Q1 2020, and its period low was $11.7 million during Q3 2022.
  • For the 3-year period, Avadel Pharmaceuticals' Other Non-Current Assets averaged around $29.7 million, with its median value being $31.5 million (2021).
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first soared by 252.68% in 2018, then plummeted by 69.24% in 2022.
  • Avadel Pharmaceuticals' Other Non-Current Assets (Quarterly) stood at $36.1 million in 2018, then climbed by 8.65% to $39.3 million in 2019, then slumped by 36.50% to $24.9 million in 2020, then skyrocketed by 35.44% to $33.8 million in 2021, then tumbled by 69.24% to $11.7 million in 2022.
  • Its last three reported values are $11.7 million in Q3 2022, $11.8 million for Q2 2022, and $39.6 million during Q1 2022.